Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 8,135 Cr.
- Current Price ₹ 1,593
- High / Low ₹ 2,449 / 1,507
- Stock P/E 44.7
- Book Value ₹ 282
- Dividend Yield 0.63 %
- ROCE 18.7 %
- ROE 14.0 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 28.1%
Cons
- The company has delivered a poor sales growth of 9.62% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,552 | |
| 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,267 | |
| Operating Profit | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 285 |
| OPM % | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 18% |
| 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 31 | |
| Interest | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 |
| Depreciation | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 72 |
| Profit before tax | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 244 |
| Tax % | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | |
| 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 182 | |
| EPS in Rs | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 35.63 |
| Dividend Payout % | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 10% |
| 3 Years: | 1% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -4% |
| 3 Years: | -16% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 21% |
| 3 Years: | 16% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 | 1,433 |
| 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 | 2 | |
| 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 | 322 | |
| Total Liabilities | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
| 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 | 1,039 | |
| CWIP | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 | 76 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 | 0 |
| 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 | 651 | |
| Total Assets | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,767 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46 | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | 275 | 263 | |
| -26 | -31 | -35 | -65 | -132 | -67 | -41 | -213 | -206 | -277 | -121 | -196 | |
| -13 | -36 | -68 | -2 | 32 | -60 | -135 | -86 | -57 | 8 | -140 | -49 | |
| Net Cash Flow | 7 | -6 | -2 | -3 | 2 | 17 | 12 | 65 | -58 | -21 | 13 | 18 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 |
| Inventory Days | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 |
| Days Payable | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 |
| Cash Conversion Cycle | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 |
| Working Capital Days | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 |
| ROCE % | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% |
Documents
Announcements
-
Board Meeting Intimation for Board Meeting To Consider & Approve Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025
16 Jan - Board meeting on Feb 3, 2026 to approve unaudited Q3/9M results for period ended Dec 31, 2025.
-
Clarification On Significant Increase In Volume
9 Jan - Alkyl Amines clarifies Jan 9, 2026 (scrip 506767): no undisclosed information causing recent volume surge.
-
Clarification sought from Alkyl Amines Chemicals Ltd
9 Jan - Exchange has sought clarification from Alkyl Amines Chemicals Ltd on January 9, 2026, with reference to Movement in Volume.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan
-
Announcement under Regulation 30 (LODR)-Credit Rating
29 Dec - CRISIL reaffirmed Alkyl Amines' ratings: CRISIL AA-/Stable and A1+ for Rs.189.38 crore facilities on Dec 29, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
Nov 2025TranscriptPPTREC
-
May 2025TranscriptPPT
-
Nov 2024TranscriptPPT
-
May 2024Transcript PPT REC
-
May 2024TranscriptAI SummaryPPTREC
-
Nov 2023TranscriptPPTREC
-
May 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Jun 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Jun 2017TranscriptPPT
-
May 2016TranscriptPPT
Business Leadership
The company is a leading manufacturer and global supplier of aliphatic amines, amine derivatives, and specialty chemicals. It offers over 100 products and is a global leader in several products, including synthetic Acetonitrile, DMAHCL, Triethylamine, Diethylhydroxylamine, and is the sole global producer of many specialty amines. [1]